AscellaHealth’s PharmaFlexFund™, Pharmaceutical Financial Solution for Expensive Specialty Therapies, Shortlisted for Innovation of the Year Award

DUBLIN--(BUSINESS WIRE)--A new global pharmaceutical financial solution created to enable industry stakeholders to meet the affordability challenges of expensive treatments for rare and complex diseases has been shortlisted for a healthcare Innovation of the Year award.

PharmaFlexFund, developed by global healthcare and business consulting services provider AscellaHealth EU/UK, brings fundamental change to the specialty pharmacy and healthcare services sector.

To read more, click here.